Early Sepsis Recognition Platform Could Identify Pre-Symptomatic Patients at POC Using Culture-Free Diagnostic Test
By HospiMedica International staff writers Posted on 14 Dec 2022 |
Early sepsis recognition is vital in improving patient prognosis and reducing mortality. Now, a new diagnostic system for early-stage sepsis condition could allow doctors to predict the future appearance and evolution of sepsis within a short period of time and thus, provide a suitable clinical response even before the symptoms arise.
DeepUll (Barcelona, Spain), a biotech company, is creating rapid, affordable and accessible diagnostic solutions with a specific focus on culture-free diagnostics to enable sepsis recognition in pre-symptomatic patients. DeepUll’s technology aims to not only rapidly identify the causative infective agent(s) within a few hours, but will also provide phenotypic antimicrobial susceptibility results, thus reducing the unnecessary use of antimicrobials. The product will also utilize artificial intelligence (AI) to offer seamless medical decision support across all phases of patient management, from early disease recognition, to precise diagnostics, up to therapy guidance.
DeepUll’s first-in-class sepsis recognition platform is designed to detect more than 250 different pathogens and about 15 resistance genes in one hour starting from 10mL of whole blood. The product will generate phenotypic antimicrobial susceptibility results in about eight hours, without requiring a positive blood culture. The product will be a desktop system with end-to-end automation with the aim to be placed in any clinical setting (laboratory, ER, ICU).
“Early identification of sepsis is absolutely crucial to a patient’s prognosis, but the tools caregivers have available today are woefully inadequate,” said Jordi Carrera, Chief Executive Officer and Co-Founder of DeepUll. “Our mission is to change this and this financing will allow us to ramp up our efforts to bring our first-in-class sepsis recognition platform to market.”
Related Links:
DeepUll
Latest Critical Care News
- Specialized Stent that Expands as Child Grows to Result in Fewer Heart Surgeries for Babies
- Next-Gen Wearable Continuous Glucose Monitoring System to Revolutionize Diabetes Management
- Machine Learning Could Reduce Hospitalizations by 30% During Pandemic
- AI-Based System Reduces Risk of Unexpected Deaths in Hospitalized Patients
- Pioneering Application Detects Pulse Pressure Using Smartphone
- Mitral Valve Repair Via Catheter Offers Better Outcomes Than Pharmacological Treatment in Heart Failure Patients
- Wearable Lung Patch Accurately Detects Asthma and COPD
- Novel Device-Based Therapies Could Overcome Limitations of Pharmacologic Therapies for Heart Failure Patients
- Wearable Sleep Trackers Could Predict Blood Biomarkers of Alzheimer’s Disease in At-Risk Individuals
- Ultra-Flexible Brain Probes Accurately Record Brain Activity Without Causing Tissue Damage
- AI-Driven Tool to Revolutionize Brain Pressure Monitoring in Intensive Care Patients
- AI-Enabled Digital Stethoscope Doubles Detection of Pregnancy Heart Failure
- Simplified Atrial Fibrillation Ablation Technique Benefits Heart Failure Patients
- Electronic Finger Wrap Uses Sweat for Automatic Monitoring of Vital Chemical Levels
- Wearable Heart Monitor Increases Diagnoses of Common Heart Rhythm Disorder By 50%
- New Chronic Coronary Syndrome Guidelines Expand Diagnostic Tools